Human resident memory T cells exit the skin and mediate systemic Th2-driven inflammation.
Johanna StroblLaura-Marie GailLisa KleisslRam Vinay PandeyValerie SmejkalJulian HuberViktoria PuxkandlLuisa UnterluggauerRuth Dingelmaier-HovorkaDenise AtzmüllerThomas KrausgruberChristoph BockPhilipp WohlfarthWerner RabitschGeorg StaryPublished in: The Journal of experimental medicine (2021)
Emigration of tissue-resident memory T cells (TRMs) was recently introduced in mouse models and may drive systemic inflammation. Skin TRMs of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) can coexist beside donor T cells, offering a unique human model system to study T cell migration. By genotyping, mathematical modeling, single-cell transcriptomics, and functional analysis of patient blood and skin T cells, we detected a small consistent population of circulating skin-derived T cells with a TRM phenotype (cTRMs) in the blood and unveil their skin origin and striking resemblance to skin TRMs. Blood from patients with active graft-versus-host disease (GVHD) contains elevated numbers of host cTRMs producing pro-inflammatory Th2/Th17 cytokines and mediating keratinocyte damage. Expression of gut-homing receptors and the occurrence of cTRMs in gastrointestinal GVHD lesions emphasize their potential to reseed and propagate inflammation in distant organs. Collectively, we describe a distinct circulating T cell population mirroring skin inflammation, which could serve as a biomarker or therapeutic target in GVHD.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- soft tissue
- wound healing
- oxidative stress
- single cell
- endothelial cells
- patients undergoing
- acute myeloid leukemia
- cell migration
- high throughput
- acute lymphoblastic leukemia
- poor prognosis
- working memory
- risk assessment
- patient safety
- dna methylation
- rna seq
- mouse model
- case report
- genome wide
- pluripotent stem cells
- human health
- drug induced